Author/Authors :
Salehi Mehdi نويسنده , Karimi Mehrdad نويسنده Traditional Medicine Departments, Faculty of Tradition Medicine , Azizkhani Mohammad نويسنده Department of Iranian Traditional Medicine, School of Traditional Medicine, Tehran University of Medical Sciences, Tehran, IR Iran , Shakeri Ramin نويسنده , Mobli Masumeh نويسنده Department of Traditional Medicine, School of Traditional
Medicine, Tehran University of Medical Sciences, Tehran,
Iran , Saberi-Firoozi Mehdi نويسنده Digestive Disease Research Institute, Shariati Hospital,
Tehran University of Medical Sciences, Tehran, Iran , Rahimi Roja نويسنده Department of Traditional Medicine, School of Traditional
Medicine, Tehran University of Medical Sciences, Tehran,
Iran
Abstract :
Background Gastroesophageal reflux disease (GERD) is one of the
most prevalent digestive diseases. Long-term treatment and recurrence of
symptoms after discontinuation of medication are amongst its problems.
Objectives The aim of this study is to investigate the impact of myrtle
fruit syrup on the recurrence of symptoms in reflux patients after the
discontinuance of using a PPI. Methods This research is a double-blind,
randomized clinical study. With regard to withdrawal rate, 45 patients
were selected for each group. The trial was conducted at the traditional
medicine clinic at tehran university of Medical Sciences, Tehran- Iran,
between November 2014 and March 2016. Diagnosis was conducted on the
basis of the Mayo clinic standardized questionnaire. Every individual
with heartburn or regurgitation symptoms with frequency of at least once
a week was diagnosed as suffering from reflux. Omeprazole 20 mg with
fasting as well as myrtle or placebo syrup 5 mL after meal were
prescribed. Treatment duration was 6 weeks, after which the medicine was
discontinued and patients were evaluated for 2 weeks. The cases in which
recurrence of symptoms up to 14 days did not occur were considered as
being non-recurrence. Results Eighty nine people with symptoms of reflux
were studied. The recurrence of symptoms was 22 people in treatment
group and 27 people in control group with no significant difference (P
value = 0.179). Time delay in the onset of symptoms was 9.57 days in
treatment group and 6.27 days in control group which had significant
difference (P value = 0.027). Conclusions Although the recurrence of
symptoms was lower in the treatment group than in the control group,
there was no significant difference. However, treatment significantly
delayed the onset of symptoms in quantitative terms. The findings show
that further research should be implemented.